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An intense suppression of T cell proliferation to mitogens and to antigens is observed in a large number of parasitic infections. The
impairment of T cell proliferation also occurred during the acute phase of Chagas’ disease, caused by the intracellular protozoan
parasiteTrypanosomacruzi.AwealthofevidencehasaccumulatedthatillustratestheabilityofT.cruzireleasedmoleculestoinﬂuence
directly a variety of diverse immunological functions. In this paper, we review the data concerning the immunoregulatory effects
of T. cruzi Tc24 (a B cell activator antigen)and Tc52 (an immunosuppressive protein)released molecules on the host immune
system. The gene targeting approach developed to further explore the biological function(s)of Tc52 molecule, revealed interesting
unexpected functional properties. Indeed, in addition to its immunusuppressive activity a direct or indirect involvement of Tc52
gene product alone or in combination with other cellular components in T. cruzi differentiation control mechanisms have been
evidenced. Moreover, targeted Tc52 replacement allowed the obtention of parasite mutants exhibiting low virulence in vitro and
in vivo. Thus, the generation of a complete deﬁciency state of virulence factors by gene targeting should provide a means to assess
the importance of these factors in the pathophysiological processes and disease progression. It is hoped that such approaches might
allow rational design of tools to control T. cruzi infections.
INTRODUCTION
The ability of parasites to survive in the immune hosts
depends upon a variety of escape mechanisms. One of these
is the inhibition or the suppression of the immune response
of their hosts. Several possible explanations have been put
forward, such as antigenic competition, acquired tolerance,
as well as the possible blocking role of soluble antigens or
circulating immune complexes. The release by the parasites
themselves of excretory-secretory products which have po-
tent immunosuppressive activity represents another possible
explanation. Moreover, a large number of reports have de-
scribed the presence of suppressor cells (T lymphocytes and
macrophages)in humans and animals infected with various
parasites.
In the case of Chagas’ disease which remains a medical
problem of relative important proportions in Latin America
studies of the pathogenesis and immunology of the disease
aiming to disclose the molecular mechanisms underlying the
immunological alterations associated with T. cruzi infection
arecurrentlyconductedinseverallaboratoriesovertheworld.
Trypanosoma cruzi, the etiological agent of Chagas’ dis-
ease, is an obligate intracellular parasite causing chronic in-
fections in human and a large number of other mammalian
species[1].Thisprotozoanparasiteistransmittedtomanand
other vertebrate hosts in the faeces of haematophagous bugs
of the Reduviid family. The complex life cycle of T. cruzi in-
cludes different stages in the insect vector and the vertebrate
host.Therearetwoparasitestagesinthevector:epimastigotes
andmetacyclictrypomastigotes,whereasthevertebratestages
are bloodstream trypomastigotes and intracellular amastig-
otes. Chagas’disease is associated with many immunological
and immunopathological reactions. In fact,during either the
chronic or the acute phase, various autoimmune phenom-
ena were observed and could be the results of nonspeciﬁc
polyclonal activation or suppressive effects that occur dur-
ingT.cruzi infection.Theexistenceof antigenscross-reactive
between T. cruzi and mammalian cells was also reported as12 Ali Ouaissi et al. 1:1 (2001)
a possible cause of exacerbation of pathological manifesta-
tions [1].
POLYCLONAL ACTIVATION
The acute and chronic phases of a Trypanosoma cruzi in-
fection are characterized by extensive polyclonal B and T cell
activation [2]. In the early stages of infection, the number
of immunoglobulin-secreting cells in the spleen and periph-
eral lymph nodes is very high and the majority of activated
B cell secrete antibodies nonspeciﬁc for the parasite antigens.
These responses lead to the expansion of antiself clones that
may be responsible for the killing of parasitized and nonpar-
asitized cells. High cellularity (60%–70% of lymphocytes)is
concomitant with a very large lymphocyte activation. In this
phase of infection, the B cell polyclonal proliferation is char-
acterized by a typical isotypic proﬁle, IgG2a, and IgG2b, in
the spleen and lymph nodes. Such responses are often de-
scribed as polyclonal with a preferential production of these
immunoglobulin isotypes, however these responses are not
antigen speciﬁc. Spleen mRNA analysis of T. cruzi infected
mice show an indiscriminate utilization of VH gene families
with some D-proximal sets correlated with multireactivity.
The hybridomas produced by spleen B cells or lymph nodes
T cells of infected mice fail to bind parasite Ag but are au-
toreactive clones,in such a way that the antibodies recognize
natural structures like actin, tubulin, myosin, keratin, myo-
globulin, thyroglobulin, or myelin. T cells are also polyclon-
ally activated and display high levels of cytolytic and helper
cell activities, but the massive polyclonal activation is due to
the minor lymphocyte subsets, namely CD5B and γδTl y m -
phocyte.
The depletion of T cell subpopulations in mice by treat-
ing with monoclonal anti-CD4 antibodies abolishes the in-
crease of Ig secreting spleen cells. The elimination of T cells
in the infected mice blocks the increase of IgM, IgG2a, and
IgG2b secreting spleen cells characteristic of the T. cruzi in-
fection. Treatment of naive mice with the cell line G-05, iso-
lated from lymph nodes of chronic infected mice, induces a
B cell polyclonal activation similar to that of chronic phase
of infection[3].Furthermore,recentstudieshaveshownthat
immunizationofmicewithCL-14trypomastigotesgenerated
a protective response mediated by CD8 cells but does not in-
ducepolyclonallymphocyteactivation,immunosuppression,
or pathology [3].
Tc24parasitereleasedmoleculebehaves
asaB-cellactivator
Like others microorganisms, T. cruzi displays mitogenic
activities that induce the production of a large percentage
of B lymphocytes in a nonspeciﬁc manner. The isolation of
lipopolysaccharide (LPS)-like substances from T. cruzi has
been reported [4]. Furthermore, we have shown that an
octadecapeptide derived from the primary sequence of an
85kDa parasite surface protein could amplify the prolifer-
ative response of presensitized cells and could induce the
production of antibodies against heterologous antigens in
the peptide-immunized mice, thus acting as a comitogenic
molecule [5]. Moreover,our recent investigations on the im-
munogenicity of aT. cruzi Tc24 released protein has revealed
that in vivo treatment with the recombinant Tc24 protein
induces a quick increase in the number of B cell secreted im-
munoglobulins mainly of IgM isotype. The IgM response is
mostly unrelated to the antigens present in total parasite ex-
tracts or to the protein itself. Our results using euthymic and
athymic mice are suggestive of a mitogenic activity of Tc24
on B cells,that is,T cell independent [5].
Tc24 induces a strong B-lymphocyte response using in
vitroandinvivoassays,indicatingthatthenatureof theBcell
responses following Tc24 injection is indeed the polyclonal
expansion of nonspeciﬁc, nonparasite directed B cell clones,
similarly to other mitogen stimulations. A single injection of
Tc24 without any adjutants induces the production of im-
munoglobulins that are not speciﬁc for parasite antigens, as
described for other mitogenic products released by several
microorganisms like bacteria,viruses,and parasites.
Thus, although acute infection with T. cruzi results in an
intense polyclonal activation of both T and B cells, paradox-
ically, T cells isolated at the acute phase of infection show a
marked state of unresponsiveness. A variety of mechanisms
involved in T cell suppression have been described. Taking
into account the large number of data reported until now, it
is reasonable to assume that certain molecules contained in,
or released by T. cruzi,could be primarily responsible for the
host immune system dysfunction.
IMMUNOSUPPRESSION
In mice and humans, the acute phase of Chagas’ disease
is marked by a state of immunosuppression [1]. In vitro ac-
tivated T cells from infected mice show a lower IL-2 pro-
duction and proliferative response to mitogens, characteris-
tic of the immunosuppressive response. The immunodeﬁ-
ciency characteristic of the acute phase of infection in mice
is revealed by a lower humoral response against speciﬁc and
nonspeciﬁc parasite antigens. In mice, the activity of para-
site molecules and the immunosuppressive cells have been
directly implicated in the immunodeﬁciency [1]. In vitro as-
says have demonstrated that the proliferative CD4 cell re-
sponse against mitogens is high in the absence of CD8 or
macrophages, but lower than the control. In CD8 knockout
mice, the activation of CD4 cells is deﬁcient, indicating that
CD8 populations are involved in this immunosuppression.
In fact, the notion of suppressive cell populations (T cells,
NKcellsormacropahges)beinginvolvedintheimmunosup-
pression phenomenon occurring during Chagas’disease, has
been already documented by several investigators [1].
Moreover,thepresenceof parasitesuppressivefactorshas
been also reported. Indeed, it has been shown that a T. cruzi
antigen molecule SAPA (Shed acute phase antigen)exhibit-
ing a neuraminidase-transsialidase activity down-regulated
T lymphocyte proliferation as a consequence of T suppres-
sor/cytotoxic cell activation and secretion of PGE2, an im-
munoregulator effector substance [6]. Furthermore, recent
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protein could inhibit the expression of IL-2 receptor chains
and secretion of cytokines by subpopulations of activated
human T lymphocytes [7].
Tc52parasitereleasedmoleculesuppresseshumanand
murineT-cellproliferation
In recent reports we have cloned and sequenced a novel
T. cruzi cDNA encoding a parasite released protein (named
Tc52)containingatandemelyrepeatedstructurecharacteris-
ticof glutathioneS-transferase[8].Studiesinserumcontain-
ingculturesystemshowedthatnativeTc52hadnomitogenic
effect for human or murine T cells, instead Tc52 prepara-
tion at 1–4µg/ml inhibited blastogenesis induced by anti-
CD3 antibodies or ConA [9]. This inhibition was not due to
endotoxin, since the Tc52 preparations contained endotoxin
at less than 0.1µg/ml, and endotoxin itself did not inhibit
cell proliferation. The cells were not killed by Tc52 but were
inhibited from responding throughout the culture period (3
to 4 days). The earlier the Tc52 was added the more inhibi-
tion was noted. In fact,Tc52 had little suppressive activity on
lymphocyte proliferation once immune responses are initi-
ated. Indeed,treatment of responding cells with Tc52 at least
one hour before addition of triggering agents was needed to
obtain an antiproliferative effect.
MECHANISM(S) OF ACTION
Tc52asascavengerofGSHandcysteine
Tc52 native protein was eluted from S-hexyl glutathione
afﬁnity column by using glutathione (GSH)or cysteine and
not other amino acids including those in GSH (e.g.,glutamic
acid and glycine)(Figure 1) .We have hypothesized that T cell
response could be affected by Tc52 through its interaction
withGSHandcysteine.Indeed,itisinterestingtoremindthat
thediverseresponsesofTcellsappeartoinvolveacomplexse-
riesof secondarysignalsinadditiontothetriggeringof Tcell
antigen speciﬁc receptor. Moreover, it has been shown that
theextracellularconcentrationof cysteinecouldbealimiting
factor for T cell activation [11]. Indeed, the plasma cysteine
concentrationis10timeslowerthanthatof itsoxidizedform
cystine. In addition, the T cell membrane transport for cys-
tine is 10 times less efﬁcient than for cysteine. In contrast,
macrophages have the capacity to take up cystine efﬁciently
and release cysteine, therefore increasing the delivery of this
amino acid to T cells which in turn could increase their own
GSH intracellular level [20].
The data we have reported provide clear evidence indi-
cating that Tc52 which speciﬁcally interact with GSH and
its precursor cysteine, almost completely inhibited human
and mice lymphocyte proliferation in response to mitogens.
This inhibition was completely reversed by addition of ex-
ogenousGSHorcysteineatphysiologicalconcentrations,but
not methionine or other amino acids. Moreover, cells from
T. cruzi-infected mice recovered during the time of active
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Figure 1: (A)Elution proﬁles of T. cruzi Tc52-bound to S-hexyl
glutathione columns with either S-hexyl glutathione (1)or the fol-
lowing amino acids: L-cysteine (2),L-methionine (3),L-glycine (4),
glutamic acid (5). (B) After elution as described in A, the columns
from which the eluates analysed in lanes 2, 3, 4, and 5 were recov-
ered, washed with the column buffer, and loaded with the same
buffer containing S-hexyl glutathione, the corresponding eluates
were analysed in lanes 6,7,8,and 9,respectively.As shown in lane 6,
residual Tc52 could be recovered from the column which was ﬁrst
loaded with L-cysteine (lane 2). In contrast, Tc52 which still bound
to the glutathione matrix after the elution with L-methionine (3),
L-glycine (4)or Glutamic acid (5) , could be efﬁciently eluted by
S-hexyl glutathione (lanes 7, 8, 9, respectively). (C) Aliquots of the
eluted samples in A (Ia)and B (IIa)(the lanes 1, 2, 3, 4, 5, 6, 7, and
8, corresponded to the products eluted and analyzed in lanes 2, 3,
4, 5, 6, 7, and 9, respectively), were separated by SDS-PAGE, trans-
ferred to nitrocellulose ﬁlters and probed using a rabbit immune
serum to Tc52 fusion protein (cDNA encoding the Tc52 protein,
initially named TcAc2, was subcloned in pGEX-2T vector, and the
protein was produced in fusion with Schistosoma japonicum 26 kDa
glutathione S-transferase (Tc52-Sj26GST)). The fusion protein and
the corresponding antibodies were obtained as described in a pre-
vious report [10]. Ib and IIb represent control tests using samples
analysed in Ia and IIa, respectively, and treated with anti-Sj26GST
rabbit serum.
Methods: T. cruzi (Y strain)epimastigotes were maintained in cul-
turemediumasdescribedin[10].Parasitesolubleantigenswerepre-
pared and adjusted to 5mg proteins/ml in buffer (20mM HEPES,
pH 7.25,1mM EDTA,O.15M KCl supplemented with 0.5mM ﬁnal
concentration of PMSF), and passed through S-hexyl glutathione
afﬁnity matrix. The column was then washed with 30ml of the
same buffer, bound material was eluted using 20ml of buffer con-
taining 2.5mM S-hexyl glutathione (1), or 1mg/ml of either of the
following amino acids: L-cysteine (2), L-methionine (3), L-glycine
(4),or L-glutamic acid (5). The columns corresponding to the lanes
2, 3, 4, and 5 were extensively washed with buffer and loaded with
20ml of buffer containing 2.5mM S-hexyl glutathione. All the elu-
atesweredialysedagainstdistilledwaterandanalysedbySDS-PAGE.
The proteins were visualized using the silver staining method.14 Ali Ouaissi et al. 1:1 (2001)
immunosuppression showed only moderate stimulation
uponactivationwithanti-CD3antibodieswhencomparedto
normalmousespleencells.Interestingly,thelevelofanti-CD3
stimulationincreasedsigniﬁcantlyuponincubationof spleen
cells from T. cruzi-infected mice with culture medium sup-
plemented with cysteine or glutathione. Furthermore, Tc52
circulating in the blood of infected mice could be evidenced
after 11 days of infection. Moreover, no antibodies against
Tc52 could be detected during the acute phase of T. cruzi in-
fection, whereas sera from chronically infected mice reacted
against the parasite protein. It is well known that GSH deﬁ-
ciency could have dramatic consequences on the function of
the immune system [11]. Moreover, T cells have been shown
to be highly sensitive to low variations of extracellular con-
centrations of cysteine. Collectively, these data provide addi-
tional information that support the immunosuppression in
Chagas’disease where Tc52,a T. cruzi released antigen which
is a scavenger of GSH and cysteine, causes an alteration of T
cell response.
N-acetylcysteine(NAC)andglutathionemodulatethe
behaviourofT.cruziexperimentalinfection
Accordingtotheaboveobservations,wehaveexploredthe
efﬁcacyof NACorglutathionemonoester(GSE),givenorally
to T. cruzi-infected mice, on T. cruzi clearance, T cell prolif-
eration and CD4+/CD8+ T cell ratios. The results obtained
support the notion of a protective function of GSE or NAC
against T. cruzi infection in BALB/c mice [6]. As expected,
GSE, which is readily transported into cells and processed to
GSH, seems to be more efﬁcient than NAC. These data to-
gether with indications on the properties of NAC and GSE in
different biological assays, suggest that the protective effects
of GSE or NAC could be attributed to the immunomodu-
latory effects of these compounds. Up-regulation of the im-
mune system by exogenous GSE or NAC may be useful to
investigate further the beneﬁt from therapeutic use of such
components in combination with antiparasitic drugs against
T. cruzi acute phase infection.
Tc52modulatesnitricoxide(NO)synthaseandNO
productionbymacrophages
The preliminary data obtained suggested that Tc52 in-
terferes with T cell activation through its capacity to scav-
enge glutathione and its precursor cysteine. However, recent
studies have shown that GSH which constitutes the major
source of plasma thiols and the most prevalent cellular thiol
(5–10mM)is oxidized to GSSG upon its reaction with NO
underbothanaerobicandaerobicconditions[12].Inviewof
the fact that recent studies have shown that NO production
by splenic macrophages interferes with T cell proliferation in
mice infected with T. cruzi [13], we thought it would be in-
terestingtoinvestigatewhetherTc52canmodifymacrophage
NO production and cytokine gene expression.
Our studies showed that Tc52 synergizes with IFN-γ
to stimulate NO production by macrophages [14]. The in-
ducibleiNOSmRNAlevelswerealsoincreaseduponstimula-
tionofmacrophageswithTc52andIFN-γ,suggestingapossi-
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Figure 2: Panel (A)shows the ﬂuorescence intensity vs. relative cell
number, obtained using BALB/c mouse macrophages incubated at
4◦CwithTc52andtreatedwithrabbitanti-Tc52antibodiesfollowed
by ﬂuoresceine-conjugated goat anti-rabbit Ig (right peak,78% ﬂu-
orescent cells). The left peak represents cells which were incubated
intheabsenceofTc52andtreatedwiththeantibodiesasabove(12%
ﬂuorescentcells).Panel(B)showsthatTc52“sticks”tomacrophages
upon its interaction with these cells at 37◦C. Panel (C)represents
a high magniﬁcation of the same cell preparation after incubation
with Tc52. The clumps of staining could be inside the cells or could
be capped Tc52 that is on the upper surface of the cell.
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Figure3:Confocalanalysisof mouseT.cruzi-infectedmacrophages
(Mc)reacted with rabbit anti-Tc52 immune serum. Fluorescent in-
tensity was converted into colors by the computer. Positive signals
(large blue spots)are evidenced in association with T. cruzi intracel-
lular amastigotes (A). (N), Macrophage nucleus.
blecontrolthroughtranscriptionalmechanisms.ThemRNAs
affected by Tc52 included IL-1α, IL-12, and IL-10. However,
the combination of Tc52 and IFN-γ down-regulates IL-1α
and IL-10 gene expression, but not IL-12. The Tc52 did not
affect the expression of constitutively expressed gene encod-
ingGAPDH.ComplementaryexperimentsshowedthatTc52
couldbeboundtomacrophagesurfaceasevidencedbyFACS
analysis (Figure 2),and is expressed by intracellular amastig-
otes (Figure 3). The immunoﬂuorescence micrographs of
macrophagesincubatedwithTc52proteinmaysuggestacap-
ping process. In fact the clumps of staining could be inside
the cells or could be capped Tc52 that is on the upper surface
of the cell (Figure 2). Further electron microscopy studies
are required to determine how the molecule is taken by the
cells (cell surface receptors?)and how it interacts to mod-
ify the intracellular molecular events leading to macrophage
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The observations that exposure of macrophages to Tc52
induces the secretion of proinﬂammatory cytokines and NO
indicate that in addition to a T-lymphocyte-mediated im-
mune reactivity to Tc52, a direct effect of the exposure of
mononuclear phagocytes to Tc52 must be considered in
the pathogenesis of inﬂammation. In fact these inﬂamma-
tory changes induced by Tc52 may contribute to protection
againstT.cruziatanearlystageofinfectionbeforeanantigen-
speciﬁc immune response is generated. Also, the synergistic
activity of small amounts of IFN-γ and Tc52 as observed in
ourstudiesindicatesaprotectiveroleforTc52earlyduringin-
fection. However,the participation of NO in the suppression
of T cell activation has been reported in a number of other
biologicalsystems[15].Therefore,itislikelythatNOproduc-
tion during the initial phase of acute T. cruzi infection might
participate in the clearance of parasites by macrophages
whereas its overproduction during the late phase of acute in-
fectionwouldaccountfortheimmunosuppressionobserved.
The involvement of parasite soluble factors in the down-
regulation of host T cell function is not restricted to T. cruzi
but has been reported in a number of other parasite models
such as Leishmania, Entamoeba histolytica, and Trypanosoma
brucei (see ref. [14]). It is likely that these soluble factors can
elicit a complex series of cellular interactions which result in
speciﬁc immune responses or suppression depending on the
immunoregulatory balance in the host. Thus, it is tempting
to speculate that the parasite-derived factors(s)stimulate ei-
therdirectlyorindirectlymacrophagestowardsasuppressive
phenotype.
One of the consequences of Chagas’ disease is an in-
ﬂammatory damage to myocardium and skeletal muscle [1].
Multiplemechanismscanleadtomyocytedamage,including
CD8+ cytotoxic T cells, TNF-α cytotoxicity, autoantibodies
to cardiac antigens, and NO production [16]. During the
chronic phase of Chagas’disease,Tc52 produced by amastig-
otes inside T. cruzi infected cardiac endothelial cells and my-
ocytes which have a transcriptionally iNOS, could modulate
local production of NO and nitrotyrosine formation. These
factorsmightparticipateinmyocardialdysfunctionandheart
failure. To evaluate this possibility, we have recently devel-
oped transfection strategies of murine macrophages and ﬁ-
broblasts with eucaryotic plasmid constructs containing the
Tc52 encoding gene. This will enable investigations on the
effects of intracellular production of Tc52 on NO synthesis
and cytokine gene expression (Ouaissi et al.,in preparation).
DEVELOPMENT OFT.CRUZI ATTENUATED CLONES
BYTc52 GENE REPLACEMENT
Previous studies have shown that the degree of resistance
to T. cruzi varied among mice strains (see ref. [14]).An addi-
tional factor which might potentially inﬂuence the course of
disease and development or resistance is parasite strain vir-
ulence. Therefore, we have tested the feasibility of Tc52 gene
replacement and analysed the phenotype of the genetically
modiﬁed parasites in term of in vitro and in vivo parasite vir-
ulence. The results of our studies are encouraging. Indeed,
monoallelic disruption of Tc52 (Tc52+/−)resulted in the
production of T. cruzi lines which express low capacity to
proliferate in cultured mammalian cells and in BALB/c mice
whencomparedtowild-typeparasites.Surprisingly,therewas
a signiﬁcant impairment of the ability of Tc52+/− mutants
or epimastigotes carrying a Tc52 antisense construct to go
through their cycle of transformation into metacyclic trypo-
mastigotes [17].
SeveralgeneproductsthatcontrolthecellcycleinT.cruzi,
such as the conserved cdc2-related kinases have been char-
acterized. Previous studies have reported that the efﬁciency
of epimastigote to metacyclic trypomastigote morphological
transformation was signiﬁcantly reduced in the case of non-
infectiveclonesandthiscorrelateswithadecreaseof glucose-
6-phosphate dehydrogenase and 6-phosphogluconate dehy-
drogenase activities [18]. Moreover,it has been reported that
competitive inhibitors of ADP-ribosyl transferase inhibited
both the extracellular and the intracellular differentiation of
T.cruziamastigotes[19].SinceADP-ribosyltransferaseactiv-
ity is widely required in the differentiation of higher animal
cells and for efﬁcient DNA repair,these ﬁndings may suggest
that the enzyme regulates structural changes in DNA which
maybeinvolvedintherepressionandderepressionof speciﬁc
genes during parasite differentiation.
Our present ﬁnding raises an important question about
thepossibledirectorindirectinvolvementofTc52geneprod-
uct alone or in combination with other cellular components
inT.cruzidifferentiationcontrolmechanisms.Itisinteresting
to remind that Tc52 expresses a thiol transferase activity,and
that the existence of a possible relationship between proteins
involved in thiol-disulﬁde redox reactions and the regulation
of gene expression is only partially emerging. For example,it
is known that glutaredoxin are cofactors for ribonucleotide
[44, 45]. Furthermore, a functional glutaredoxin homologue
identiﬁed in the vaccinia virus has been proposed to partic-
ipate as a cofactor in the viral transcription to initiate gene
expression through its capacity to mediate the thiol-disulﬁde
conversionreactions[20].Therefore,itwouldbenotsurpris-
ingif Tc52,likeothermembersof thethiol-disulﬁdeoxidore-
ductasefamilywhichactbyshiftingthebalancebetweenglu-
tathione, disulﬁde glutahione, thiol groups of cysteines, and
protein disulﬁde bonds plays a role in the regulation of gene
expression. Further molecular in depth studies are needed to
determinetheinvolvementofTc52inT.cruzigeneexpression
regulation.
Another interesting observation related to the Tc52
down-modulation is the dramatic decrease in parasite vir-
ulence in vitro and in vivo, the reduction being even more
pronounced in the case of parasites overexpressing antisense
RNA,indicatingthereforethatwehavegeneratedmutantpar-
asites with low virulence. The availability of the mutants ob-
tained by gene targeting will allow to examine how the low
virulence expressed by T. cruzi mutant inﬂuences the nature
of the immune response during infection. Moreover, inves-
tigations on morphological changes occurring in tissues of
mutant-challenged host will determine whether mutant par-
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vaccination potential against subsequent challenge with vir-
ulent parasites have to be tested.
Similar strategy has already been applied in the case of
Leishmania major and L. donovani strains for another gene,
theTrypanothionereductaseencodinggene,requiredforpar-
asite survival [21]. Although, the TR mutant parasites have
not been studied with respect to their ability to produce dis-
ease in experimental hosts, the data obtained clearly indi-
catedecreasedsurvivalof theTRmutantinsidemacrophages
in vitro. Thus, it is likely that the genetic manipulation ap-
proaches would not only help to deﬁne the in vivo role of a
given gene product but may also be useful to develop stable
attenuated strains for vaccine development.
CONCLUDING REMARK
Parasites can elicit a complex series of cellular interac-
tions which result in speciﬁc immune responses or suppres-
siondependingontheimmunoregulatorybalanceinthehost.
Suppression appears to predominate at certain phases of the
infection. Relieving this parasite-induced immunosuppres-
sion could potentially provide a means to restore the efﬁcacy
of the immune protection mechanisms.
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